{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:58:28Z","timestamp":1790996308020,"version":"4.1.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["2421745"],"award-info":[{"award-number":["2421745"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/CRTF\/21\/24144"],"award-info":[{"award-number":["FS\/CRTF\/21\/24144"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/3\/34214"],"award-info":[{"award-number":["RE\/18\/3\/34214"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/17\/22\/32644"],"award-info":[{"award-number":["FS\/17\/22\/32644"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the progress made in risk stratification, sudden cardiac death and heart failure remain dreaded complications for hypertrophic cardiomyopathy (HCM) patients. Myocardial ischaemia is widely acknowledged as a contributor to cardiovascular events, but the assessment of ischaemia is not yet included in HCM clinical guidelines. This review aims to evaluate the HCM-specific pro-ischaemic mechanisms and the potential prognostic value of imaging for myocardial ischaemia in HCM. A literature review was performed using PubMed to identify studies with non-invasive imaging of ischaemia (cardiovascular magnetic resonance, echocardiography, and nuclear imaging) in HCM, prioritising studies published after the last major review in 2009. Other studies, including invasive ischaemia assessment and post-mortem histology, were also considered for mechanistic or prognostic relevance. Pro-ischaemic mechanisms in HCM reviewed included the effects of sarcomeric mutations, microvascular remodelling, hypertrophy, extravascular compressive forces and left ventricular outflow tract obstruction. The relationship between ischaemia and fibrosis was re-appraised by considering segment-wise analyses in multimodal imaging studies. The prognostic significance of myocardial ischaemia in HCM was evaluated using longitudinal studies with composite endpoints, and reports of ischaemia-arrhythmia associations were further considered. The high prevalence of ischaemia in HCM is explained by several micro- and macrostructural pathological features, alongside mutation-associated energetic impairment. Ischaemia on imaging identifies a subgroup of HCM patients at higher risk of adverse cardiovascular outcomes. Ischaemic HCM phenotypes are a high-risk subgroup associated with more advanced left ventricular remodelling, but further studies are required to evaluate the independent prognostic value of non-invasive imaging for ischaemia.<\/jats:p>","DOI":"10.1007\/s10554-023-02894-y","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T06:02:21Z","timestamp":1687759341000},"page":"1979-1996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"39","author":[{"given":"James A.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakariye","family":"Ashkir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Bueno-Orovio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"2894_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65:1249\u20131254. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.019","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR2","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1161\/CIR.0000000000000937","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA et al (2020) 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation 142:e558\u2013e631. https:\/\/doi.org\/10.1161\/CIR.0000000000000937","journal-title":"Circulation"},{"key":"2894_CR3","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jacc.2009.04.072","volume":"54","author":"MS Maron","year":"2009","unstructured":"Maron MS, Olivotto I, Maron BJ et al (2009) The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:866\u2013875. https:\/\/doi.org\/10.1016\/j.jacc.2009.04.072","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa025050","volume":"349","author":"F Cecchi","year":"2003","unstructured":"Cecchi F, Olivotto I, Gistri R et al (2003) Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy. N Engl J Med 349:1027\u20131035. https:\/\/doi.org\/10.1056\/NEJMoa025050","journal-title":"N Engl J Med"},{"key":"2894_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/0003319718778418","volume":"69","author":"F Liu","year":"2018","unstructured":"Liu F, Ma Y, Ge H et al (2018) Long-Term Outcomes of Acute Myocardial Infarction in Patients With Hypertrophic Cardiomyopathy. Angiology 69:900\u2013908. https:\/\/doi.org\/10.1177\/0003319718778418","journal-title":"Angiology"},{"key":"2894_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/clc.22601","volume":"40","author":"Y-J Yang","year":"2017","unstructured":"Yang Y-J, Fan C-M, Yuan J-Q et al (2017) Long-term survival after acute myocardial infarction in patients with hypertrophic cardiomyopathy. Clin Cardiol 40:26\u201331. https:\/\/doi.org\/10.1002\/clc.22601","journal-title":"Clin Cardiol"},{"key":"2894_CR7","first-page":"671","volume":"27","author":"NG Poteshkina","year":"2020","unstructured":"Poteshkina NG, Kovalevskaya EA, Krylova NS, Fettser DV (2020) Myocardial ischemia in patients with hypertrophic cardiomyopathy. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 27:671\u2013676","journal-title":"Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med"},{"key":"2894_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.07.046","author":"F Graziani","year":"2022","unstructured":"Graziani F, Lillo R, Biagini E et al (2022) Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease. Int J Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2022.07.046","journal-title":"Int J Cardiol"},{"key":"2894_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","volume":"4","author":"MS Maron","year":"2019","unstructured":"Maron MS, Rowin EJ, Wessler BS et al (2019) Enhanced American College of Cardiology\/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol 4:644\u2013657. https:\/\/doi.org\/10.1001\/jamacardio.2019.1391","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00246-021-02570-9","volume":"42","author":"L Ziolkowska","year":"2021","unstructured":"Ziolkowska L, Boruc A, Sobielarska-Lysiak D et al (2021) Prognostic Significance of Myocardial Ischemia Detected by Single-Photon Emission Computed Tomography in Children with Hypertrophic Cardiomyopathy. Pediatr Cardiol 42:960\u2013968. https:\/\/doi.org\/10.1007\/s00246-021-02570-9","journal-title":"Pediatr Cardiol"},{"key":"2894_CR11","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.ijcard.2006.07.206","volume":"115","author":"G Limongelli","year":"2007","unstructured":"Limongelli G, Calabro P, Pacileo G et al (2007) Myocardial infarction in a young athlete with non-obstructive hypertrophic cardiomyopathy and normal coronary arteries. Int J Cardiol 115:e71\u2013e73. https:\/\/doi.org\/10.1016\/j.ijcard.2006.07.206","journal-title":"Int J Cardiol"},{"key":"2894_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/jcm10040575","volume":"10","author":"M Gaspari","year":"2021","unstructured":"Gaspari M, Basso C, Perazzolo Marra M et al (2021) Small Vessel Disease: Another Component of the Hypertrophic Cardiomyopathy Phenotype Not Necessarily Associated with Fibrosis. J Clin Med 10:575. https:\/\/doi.org\/10.3390\/jcm10040575","journal-title":"J Clin Med"},{"key":"2894_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/hrt.75.2.179","volume":"75","author":"PM Elliott","year":"1996","unstructured":"Elliott PM, Rosano GM, Gill JS et al (1996) Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy. Heart 75:179. https:\/\/doi.org\/10.1136\/hrt.75.2.179","journal-title":"Heart"},{"key":"2894_CR14","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/01.CIR.76.6.1214","volume":"76","author":"PT O\u2019Gara","year":"1987","unstructured":"O\u2019Gara PT, Bonow RO, Maron BJ et al (1987) Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 76:1214\u20131223. https:\/\/doi.org\/10.1161\/01.CIR.76.6.1214","journal-title":"Circulation"},{"key":"2894_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/0002-9149(89)90428-1","volume":"64","author":"TW Dohlen","year":"1989","unstructured":"Dohlen TW, Prisant LM, Frank MJ (1989) Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy. Am J Cardiol 64:498\u2013503. https:\/\/doi.org\/10.1016\/0002-9149(89)90428-1","journal-title":"Am J Cardiol"},{"key":"2894_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1161\/01.CIR.79.5.1052","volume":"79","author":"JE Udelson","year":"1989","unstructured":"Udelson JE, Bonow RO, O\u2019Gara PT et al (1989) Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 79:1052\u20131060. https:\/\/doi.org\/10.1161\/01.CIR.79.5.1052","journal-title":"Circulation"},{"key":"2894_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0002-9149(93)90162-6","volume":"72","author":"J Takata","year":"1993","unstructured":"Takata J, Counihan PJ, Gane JN et al (1993) Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain. Am J Cardiol 72:211\u2013217. https:\/\/doi.org\/10.1016\/0002-9149(93)90162-6","journal-title":"Am J Cardiol"},{"key":"2894_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/0735-1097(93)90193-5","volume":"22","author":"V Dilsizian","year":"1993","unstructured":"Dilsizian V, Bonow RO, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22:796\u2013804. https:\/\/doi.org\/10.1016\/0735-1097(93)90193-5","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0167-5273(95)02536-7","volume":"54","author":"M Shimizu","year":"1996","unstructured":"Shimizu M, Yoshio H, Ino H et al (1996) Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R, S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy. Int J Cardiol 54:51\u201359. https:\/\/doi.org\/10.1016\/0167-5273(95)02536-7","journal-title":"Int J Cardiol"},{"key":"2894_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/oxfordjournals.eurheartj.a015002","volume":"17","author":"PM Elliott","year":"1996","unstructured":"Elliott PM, Kaski JC, Prasad K et al (1996) Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. Eur Heart J 17:1056\u20131064. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a015002","journal-title":"Eur Heart J"},{"key":"2894_CR21","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0735-1097(98)00498-7","volume":"32","author":"N Yoshida","year":"1998","unstructured":"Yoshida N, Ikeda H, Wada T et al (1998) Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 32:1938\u20131942. https:\/\/doi.org\/10.1016\/S0735-1097(98)00498-7","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1053\/euhj.1997.0769","volume":"19","author":"M Yamada","year":"1998","unstructured":"Yamada M, Elliott PM, Kaski JC et al (1998) Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. Eur Heart J 19:500\u2013507. https:\/\/doi.org\/10.1053\/euhj.1997.0769","journal-title":"Eur Heart J"},{"key":"2894_CR23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.nuclcard.2004.05.008","volume":"11","author":"G Romero-Farina","year":"2004","unstructured":"Romero-Farina G, Candell-Riera J, Galve E et al (2004) Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications? J Nucl Cardiol 11:578\u2013586. https:\/\/doi.org\/10.1016\/j.nuclcard.2004.05.008","journal-title":"J Nucl Cardiol"},{"key":"2894_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ijcard.2007.06.023","volume":"128","author":"P Melacini","year":"2008","unstructured":"Melacini P, Corbetti F, Calore C et al (2008) Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy. Int J Cardiol 128:364\u2013373. https:\/\/doi.org\/10.1016\/j.ijcard.2007.06.023","journal-title":"Int J Cardiol"},{"key":"2894_CR25","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.amjcard.2008.08.023","volume":"102","author":"L Cortigiani","year":"2008","unstructured":"Cortigiani L, Rigo F, Gherardi S et al (2008) Prognostic Implications of Coronary Flow Reserve on Left Anterior Descending Coronary Artery in Hypertrophic Cardiomyopathy. Am J Cardiol 102:1718\u20131723. https:\/\/doi.org\/10.1016\/j.amjcard.2008.08.023","journal-title":"Am J Cardiol"},{"key":"2894_CR26","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1253\/circj.CJ-10-0241","volume":"74","author":"J Moon","year":"2010","unstructured":"Moon J, Cho IJ, Shim CY et al (2010) Abnormal Myocardial Capillary Density in Apical Hypertrophic Cardiomyopathy Can Be Assessed by Myocardial Contrast Echocardiography. Circulation 74:2166\u20132172. https:\/\/doi.org\/10.1253\/circj.CJ-10-0241","journal-title":"Circulation"},{"key":"2894_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2967\/jnumed.111.096156","volume":"53","author":"PE Bravo","year":"2012","unstructured":"Bravo PE, Pinheiro A, Higuchi T et al (2012) PET\/CT Assessment of Symptomatic Individuals with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy. J Nucl Med 53:407. https:\/\/doi.org\/10.2967\/jnumed.111.096156","journal-title":"J Nucl Med"},{"key":"2894_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/CIRCIMAGING.112.000110","volume":"6","author":"PE Bravo","year":"2013","unstructured":"Bravo PE, Zimmerman SL, Luo H-C et al (2013) Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 6:210\u2013217. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000110","journal-title":"Circ Cardiovasc Imaging"},{"key":"2894_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCIMAGING.112.000170","volume":"6","author":"CC Tyan","year":"2013","unstructured":"Tyan CC, Armstrong S, Scholl D et al (2013) Stress Hypoperfusion and Tissue Injury in Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging 6:229\u2013238. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000170","journal-title":"Circ Cardiovasc Imaging"},{"key":"2894_CR30","doi-asserted-by":"publisher","first-page":"P324","DOI":"10.1186\/1532-429X-16-S1-P324","volume":"16","author":"A Villa","year":"2014","unstructured":"Villa A, Bettencourt N, Zarinabad N et al (2014) Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement. J Cardiovasc Magn Reson 16:P324\u2013P324. https:\/\/doi.org\/10.1186\/1532-429X-16-S1-P324","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12968-014-0049-1","volume":"16","author":"T Ismail","year":"2014","unstructured":"Ismail T, Hsu L-Y, Greve A et al (2014) Coronary microvascular ischemia in hypertrophic cardiomyopathy: a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson 16:49. https:\/\/doi.org\/10.1186\/s12968-014-0049-1","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ehjci\/jeu225","volume":"16","author":"J Peteiro","year":"2015","unstructured":"Peteiro J, Fernandez X, Bouzas-Mosquera A et al (2015) Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 16:423\u2013432. https:\/\/doi.org\/10.1093\/ehjci\/jeu225","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2894_CR33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00246-015-1214-5","volume":"36","author":"R Jablonowski","year":"2015","unstructured":"Jablonowski R, Fernlund E, Aletras AH et al (2015) Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients. Pediatr Cardiol 36:1662\u20131669. https:\/\/doi.org\/10.1007\/s00246-015-1214-5","journal-title":"Pediatr Cardiol"},{"key":"2894_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.crad.2014.12.018","volume":"70","author":"A Chiribiri","year":"2015","unstructured":"Chiribiri A, Leuzzi S, Conte MR et al (2015) Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death. Clin Radiol 70:495\u2013501. https:\/\/doi.org\/10.1016\/j.crad.2014.12.018","journal-title":"Clin Radiol"},{"key":"2894_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijcard.2016.06.044","volume":"219","author":"Q Ciampi","year":"2016","unstructured":"Ciampi Q, Olivotto I, Gardini C et al (2016) Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: the International Stress Echo Registry. Int J Cardiol 219:331\u2013338. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.044","journal-title":"Int J Cardiol"},{"key":"2894_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-016-0223-8","author":"ADM Villa","year":"2016","unstructured":"Villa ADM, Sammut E, Zarinabad N et al (2016) Microvascular ischemia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. https:\/\/doi.org\/10.1186\/s12968-016-0223-8","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1017\/S1047951118000094","volume":"28","author":"LE Hernandez","year":"2018","unstructured":"Hernandez LE (2018) Myocardial stress perfusion magnetic resonance in children with hypertrophic cardiomyopathy. Cardiol Young 28:702\u2013708. https:\/\/doi.org\/10.1017\/S1047951118000094","journal-title":"Cardiol Young"},{"key":"2894_CR38","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/heartjnl-2019-315848","volume":"106","author":"C Camaioni","year":"2020","unstructured":"Camaioni C, Knott KD, Augusto JB et al (2020) Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy. Heart 106:824\u2013829. https:\/\/doi.org\/10.1136\/heartjnl-2019-315848","journal-title":"Heart"},{"key":"2894_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ehjci\/jey135","volume":"20","author":"B Raman","year":"2019","unstructured":"Raman B, Ariga R, Spartera M et al (2019) Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications. Eur Heart J Cardiovasc Imaging 20:157\u2013167. https:\/\/doi.org\/10.1093\/ehjci\/jey135","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2894_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12968-020-00623-1","volume":"22","author":"EK Kim","year":"2020","unstructured":"Kim EK, Lee S-C, Chang S-A et al (2020) Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 22:30. https:\/\/doi.org\/10.1186\/s12968-020-00623-1","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR41","doi-asserted-by":"publisher","first-page":"15977","DOI":"10.1038\/s41598-020-71394-z","volume":"10","author":"M Malahfji","year":"2020","unstructured":"Malahfji M, Senapati A, Debs D et al (2020) Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy. Sci Rep 10:15977. https:\/\/doi.org\/10.1038\/s41598-020-71394-z","journal-title":"Sci Rep"},{"key":"2894_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12968-021-00720-9","volume":"23","author":"CE Raphael","year":"2021","unstructured":"Raphael CE, Mitchell F, Kanaganayagam GS et al (2021) Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation. J Cardiovasc Magn Reson 23:26. https:\/\/doi.org\/10.1186\/s12968-021-00720-9","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020227","author":"RK Hughes","year":"2021","unstructured":"Hughes RK, Camaioni C, Augusto JB et al (2021) Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.120.020227","journal-title":"J Am Heart Assoc"},{"key":"2894_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.761860","author":"S Aguiar Rosa","year":"2021","unstructured":"Aguiar Rosa S, Thomas B, Fiarresga A et al (2021) The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.761860","journal-title":"Front Cardiovasc Med"},{"key":"2894_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1532-429X-12-29","volume":"12","author":"M Hamon","year":"2010","unstructured":"Hamon M, Fau G, N\u00e9e G et al (2010) Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 12:29. https:\/\/doi.org\/10.1186\/1532-429X-12-29","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR46","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jacc.2012.12.024","volume":"61","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Dass S, Suttie J et al (2013) Blunted Myocardial Oxygenation Response During Vasodilator Stress in Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol 61:1169\u20131176. https:\/\/doi.org\/10.1016\/j.jacc.2012.12.024","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR47","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1053\/hupa.2000.16659","volume":"31","author":"C Basso","year":"2000","unstructured":"Basso C, Thiene G, Corrado D et al (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988\u2013998. https:\/\/doi.org\/10.1053\/hupa.2000.16659","journal-title":"Hum Pathol"},{"key":"2894_CR48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jacc.2003.09.046","volume":"43","author":"R Krams","year":"2004","unstructured":"Krams R, Cate FJ, Carlier SG et al (2004) Diastolic coronary vascular reserve: a new index to detect changes in the coronary microcirculation in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:670\u2013677. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.046","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.amjcard.2020.04.021","volume":"127","author":"BJ Maron","year":"2020","unstructured":"Maron BJ, Mackey-Bojack S, Facile E et al (2020) Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy. Am J Cardiol 127:139\u2013141. https:\/\/doi.org\/10.1016\/j.amjcard.2020.04.021","journal-title":"Am J Cardiol"},{"key":"2894_CR50","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","volume":"54","author":"DH Kwon","year":"2009","unstructured":"Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac Magnetic Resonance Detection of Myocardial Scarring in Hypertrophic Cardiomyopathy: Correlation With Histopathology and Prevalence of Ventricular Tachycardia. J Am Coll Cardiol 54:242\u2013249. https:\/\/doi.org\/10.1016\/j.jacc.2009.04.026","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","volume":"8","author":"BJ Maron","year":"1986","unstructured":"Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545\u2013557. https:\/\/doi.org\/10.1016\/S0735-1097(86)80181-4","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","volume":"6","author":"G Moravsky","year":"2013","unstructured":"Moravsky G, Ofek E, Rakowski H et al (2013) Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Accurate Reflection of Histopathological Findings by CMR. JACC Cardiovasc Imaging 6:587\u2013596. https:\/\/doi.org\/10.1016\/j.jcmg.2012.09.018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2894_CR53","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/0002-9149(79)90139-5","volume":"43","author":"BJ Maron","year":"1979","unstructured":"Maron BJ, Epstein SE, Roberts WC (1979) Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 43:1086\u20131102. https:\/\/doi.org\/10.1016\/0002-9149(79)90139-5","journal-title":"Am J Cardiol"},{"key":"2894_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.18087\/cardio.2021.12.n1718","volume":"61","author":"F Bogatyreva","year":"2021","unstructured":"Bogatyreva F, Kaplunova VRA, Kozhevnikova M et al (2021) Assessment of the structural and functional state of blood vessels in patients with hypertrophic cardiomyopathy. Kardiologiia 61:16\u201321","journal-title":"Kardiologiia"},{"key":"2894_CR55","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/01.CIR.75.6.1130","volume":"75","author":"M Tanaka","year":"1987","unstructured":"Tanaka M, Fujiwara H, Onodera T et al (1987) Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 75:1130\u20131139. https:\/\/doi.org\/10.1161\/01.CIR.75.6.1130","journal-title":"Circulation"},{"key":"2894_CR56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/01.CIR.97.3.230","volume":"97","author":"R Krams","year":"1998","unstructured":"Krams R, Kofflard MJM, Duncker DJ et al (1998) Decreased Coronary Flow Reserve in Hypertrophic Cardiomyopathy Is Related to Remodeling of the Coronary Microcirculation. Circulation 97:230\u2013233. https:\/\/doi.org\/10.1161\/01.CIR.97.3.230","journal-title":"Circulation"},{"key":"2894_CR57","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0735-1097(98)00036-9","volume":"31","author":"B Schwartzkopff","year":"1998","unstructured":"Schwartzkopff B, Mundhenke M, Strauer BE (1998) Alterations of the Architecture of Subendocardial Arterioles in Patients With Hypertrophic Cardiomyopathy and Impaired Coronary Vasodilator Reserve: A Possible Cause for Myocardial Ischemia. J Am Coll Cardiol 31:1089\u20131096. https:\/\/doi.org\/10.1016\/S0735-1097(98)00036-9","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/heart.84.5.476","volume":"84","author":"AM Varnava","year":"2000","unstructured":"Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476\u2013482. https:\/\/doi.org\/10.1136\/heart.84.5.476","journal-title":"Heart"},{"key":"2894_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2019.03.060","volume":"291","author":"A Fo\u00e0","year":"2019","unstructured":"Fo\u00e0 A, Agostini V, Rapezzi C et al (2019) Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy. Int J Cardiol 291:77\u201382. https:\/\/doi.org\/10.1016\/j.ijcard.2019.03.060","journal-title":"Int J Cardiol"},{"key":"2894_CR60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijcard.2007.04.003","volume":"126","author":"B Johansson","year":"2008","unstructured":"Johansson B, M\u00f6rner S, Waldenstr\u00f6m A, St\u00e5l P (2008) Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis. Int J Cardiol 126:252\u2013257. https:\/\/doi.org\/10.1016\/j.ijcard.2007.04.003","journal-title":"Int J Cardiol"},{"key":"2894_CR61","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/eci.12544","volume":"45","author":"A G\u00fc\u00e7l\u00fc","year":"2015","unstructured":"G\u00fc\u00e7l\u00fc A, Happ\u00e9 C, Eren S et al (2015) Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype. Eur J Clin Invest 45:1252\u20131259. https:\/\/doi.org\/10.1111\/eci.12544","journal-title":"Eur J Clin Invest"},{"key":"2894_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232427","author":"LLAM Nijenkamp","year":"2020","unstructured":"Nijenkamp LLAM, Bollen IAE, Niessen HWM et al (2020) Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0232427","journal-title":"PLoS ONE"},{"key":"2894_CR63","doi-asserted-by":"publisher","first-page":"E042","DOI":"10.1532\/hsf.4277","volume":"25","author":"M-K Zhang","year":"2022","unstructured":"Zhang M-K, Zhang Z, Xue H et al (2022) Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy: A Histopathological Comparison of Pediatric and Adult Patients. Heart Surg Forum 25:E042\u2013E047. https:\/\/doi.org\/10.1532\/hsf.4277","journal-title":"Heart Surg Forum"},{"key":"2894_CR64","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","volume":"54","author":"MS Maron","year":"2009","unstructured":"Maron MS, Maron BJ, Harrigan C et al (2009) Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance. J Am Coll Cardiol 54:220\u2013228. https:\/\/doi.org\/10.1016\/j.jacc.2009.05.006","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR65","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","volume":"114","author":"MS Maron","year":"2006","unstructured":"Maron MS, Olivotto I, Zenovich AG et al (2006) Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Circulation 114:2232\u20132239. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.644682","journal-title":"Circulation"},{"key":"2894_CR66","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/hrt.2007.126003","volume":"94","author":"JS Shah","year":"2008","unstructured":"Shah JS, Esteban MTT, Thaman R et al (2008) Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart 94:1288. https:\/\/doi.org\/10.1136\/hrt.2007.126003","journal-title":"Heart"},{"key":"2894_CR67","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003132","author":"P Patel","year":"2015","unstructured":"Patel P, Dhillon A, Popovic ZB et al (2015) Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.003132","journal-title":"Circ Cardiovasc Imaging"},{"key":"2894_CR68","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.echo.2013.03.023","volume":"26","author":"M Tesic","year":"2013","unstructured":"Tesic M, Djordjevic-Dikic A, Beleslin B et al (2013) Regional Difference of Microcirculation in Patients with Asymmetric Hypertrophic Cardiomyopathy: Transthoracic Doppler Coronary Flow Velocity Reserve Analysis. J Am Soc Echocardiogr 26:775\u2013782. https:\/\/doi.org\/10.1016\/j.echo.2013.03.023","journal-title":"J Am Soc Echocardiogr"},{"key":"2894_CR69","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1161\/01.CIR.96.3.834","volume":"96","author":"MK Kyriakidis","year":"1997","unstructured":"Kyriakidis MK, Dernellis JM, Androulakis AE et al (1997) Changes in Phasic Coronary Blood Flow Velocity Profile and Relative Coronary Flow Reserve in Patients With Hypertrophic Obstructive Cardiomyopathy. Circulation 96:834\u2013841. https:\/\/doi.org\/10.1161\/01.CIR.96.3.834","journal-title":"Circulation"},{"key":"2894_CR70","doi-asserted-by":"publisher","first-page":"H986","DOI":"10.1152\/ajpheart.00233.2007","volume":"294","author":"P Knaapen","year":"2008","unstructured":"Knaapen P, Germans T, Camici PG et al (2008) Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 294:H986\u2013H993. https:\/\/doi.org\/10.1152\/ajpheart.00233.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2894_CR71","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/hrt.2006.110460","volume":"93","author":"OII Soliman","year":"2007","unstructured":"Soliman OII, Knaapen P, Geleijnse ML et al (2007) Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography. Heart 93:1204\u20131212. https:\/\/doi.org\/10.1136\/hrt.2006.110460","journal-title":"Heart"},{"key":"2894_CR72","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ejrad.2014.01.008","volume":"83","author":"H Xu","year":"2014","unstructured":"Xu H, Yang Z, Sun J et al (2014) The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: Assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance. Eur Radiol 83:665\u2013672. https:\/\/doi.org\/10.1016\/j.ejrad.2014.01.008","journal-title":"Eur Radiol"},{"key":"2894_CR73","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jacc.2016.07.751","volume":"68","author":"CE Raphael","year":"2016","unstructured":"Raphael CE, Cooper R, Parker KH et al (2016) Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance. J Am Coll Cardiol 68:1651\u20131660. https:\/\/doi.org\/10.1016\/j.jacc.2016.07.751","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR74","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1002\/jum.14250","volume":"36","author":"W Liu","year":"2017","unstructured":"Liu W, Sun D, Yang J (2017) Diastolic Dysfunction of Hypertrophic Cardiomyopathy Genotype-Positive Subjects Without Hypertrophy Is Detected by Tissue Doppler Imaging: A Systematic Review and Meta-analysis. J Ultrasound Med 36:2093\u20132103. https:\/\/doi.org\/10.1002\/jum.14250","journal-title":"J Ultrasound Med"},{"key":"2894_CR75","doi-asserted-by":"publisher","first-page":"725.e1","DOI":"10.1016\/j.ahj.2005.12.005","volume":"151","author":"T Poutanen","year":"2006","unstructured":"Poutanen T, Tikanoja T, J\u00e4\u00e4skel\u00e4inen P et al (2006) Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy\u2013causing mutations in the \u03b2-myosin heavy chain, \u03b1-tropomyosin, and myosin-binding protein C genes. Am Heart J 151:725.e1-725.e9. https:\/\/doi.org\/10.1016\/j.ahj.2005.12.005","journal-title":"Am Heart J"},{"key":"2894_CR76","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00424-018-2224-y","volume":"471","author":"RJ Marszalek","year":"2019","unstructured":"Marszalek RJ, John Solaro R, Wolska BM (2019) Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy. Pflug Arch Eur J Physiol 471:769\u2013780. https:\/\/doi.org\/10.1007\/s00424-018-2224-y","journal-title":"Pflug Arch Eur J Physiol"},{"key":"2894_CR77","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12350-008-9031-3","volume":"16","author":"G Plehn","year":"2009","unstructured":"Plehn G, Vormbrock J, Meissner A, Trappe H-J (2009) Effects of exercise on the duration of diastole and on interventricular phase differences in patients with hypertrophic cardiomyopathy: relationship to cardiac output reserve. J Nucl Cardiol 16:233\u2013243. https:\/\/doi.org\/10.1007\/s12350-008-9031-3","journal-title":"J Nucl Cardiol"},{"key":"2894_CR78","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/0002-9149(93)90191-E","volume":"72","author":"Y Tomochika","year":"1993","unstructured":"Tomochika Y, Tanaka N, Wasaki Y et al (1993) Assessment of flow profile of left anterior descending coronary artery in hypertrophic cardiomyopathy by transesophageal pulsed Doppler echocardiography. Am J Cardiol 72:1425\u20131430. https:\/\/doi.org\/10.1016\/0002-9149(93)90191-E","journal-title":"Am J Cardiol"},{"key":"2894_CR79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0894-7317(14)80413-6","volume":"7","author":"T Akasaka","year":"1994","unstructured":"Akasaka T, Yoshikawa J, Yoshida K et al (1994) Phasic Coronary Flow Characteristics in Patients With Hypertrophic Cardiomyopathy: A Study by Coronary Doppler Catheter. J Am Soc Echocardiogr 7:9\u201319. https:\/\/doi.org\/10.1016\/S0894-7317(14)80413-6","journal-title":"J Am Soc Echocardiogr"},{"key":"2894_CR80","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0002-8703(99)70466-7","volume":"137","author":"S Hirasaki","year":"1999","unstructured":"Hirasaki S, Nakamura T, Kuribayashi T et al (1999) Abnormal course, abnormal flow, and systolic compression of the septal perforator associated with impaired myocardial perfusion in hypertrophic cardiomyopathy. Am Heart J 137:109\u2013117. https:\/\/doi.org\/10.1016\/s0002-8703(99)70466-7","journal-title":"Am Heart J"},{"key":"2894_CR81","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","volume":"30","author":"C Basso","year":"2009","unstructured":"Basso C, Thiene G, Mackey-Bojack S et al (2009) Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J 30:1627\u20131634. https:\/\/doi.org\/10.1093\/eurheartj\/ehp121","journal-title":"Eur Heart J"},{"key":"2894_CR82","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcct.2014.09.007","volume":"8","author":"M Shariat","year":"2014","unstructured":"Shariat M, Thavendiranathan P, Nguyen E et al (2014) Utility of coronary CT angiography in outpatients with hypertrophic cardiomyopathy presenting with angina symptoms. J Cardiovasc Comput Tomogr 8:429\u2013437. https:\/\/doi.org\/10.1016\/j.jcct.2014.09.007","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2894_CR83","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1177\/2150135114536901","volume":"5","author":"O Yildiz","year":"2014","unstructured":"Yildiz O, Altin FH, Tosun O et al (2014) Myocardial Bridging in a Child With Hypertrophic Obstructive Cardiomyopathy. World J Pediatr Congenit Heart Surg 5:611\u2013614. https:\/\/doi.org\/10.1177\/2150135114536901","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"2894_CR84","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ncpcardio1420","volume":"6","author":"I Olivotto","year":"2009","unstructured":"Olivotto I, Cecchi F, Bini R et al (2009) Tunneled left anterior descending artery in a child with hypertrophic cardiomyopathy. Nat Clin Pract Cardiovasc Med 6:134\u2013139. https:\/\/doi.org\/10.1038\/ncpcardio1420","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2894_CR85","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/2150135120943869","volume":"12","author":"S Said","year":"2020","unstructured":"Said S (2020) Unroofing of LAD Myocardial Bridge Combined With Right Ventricular Septal Myectomy in a Child With Noonan Syndrome and HCM. World J Pediatr Congenit Heart Surg 12:659\u2013660. https:\/\/doi.org\/10.1177\/2150135120943869","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"2894_CR86","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1749-8090-4-51","volume":"4","author":"AF Popov","year":"2009","unstructured":"Popov AF, Bireta C, Schmitto JD et al (2009) Myocardial ischemia with left ventricular outflow obstruction. J Cardiothorac Surg 4:51. https:\/\/doi.org\/10.1186\/1749-8090-4-51","journal-title":"J Cardiothorac Surg"},{"key":"2894_CR87","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0735-1097(01)01461-9","volume":"38","author":"BW McCrindle","year":"2001","unstructured":"McCrindle BW, Yetman AT (2001) Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy. J Am Coll Cardiol 38:921\u2013922. https:\/\/doi.org\/10.1016\/S0735-1097(01)01461-9","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR88","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S0735-1097(01)01462-0","volume":"38","author":"FAMS Lameh","year":"2001","unstructured":"Lameh FAMS, Joanna S (2001) Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: reply. J Am Coll Cardiol 38:922. https:\/\/doi.org\/10.1016\/S0735-1097(01)01462-0","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR89","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/ehjci\/jey220","volume":"20","author":"S Grover","year":"2019","unstructured":"Grover S, Lloyd R, Perry R et al (2019) Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study. Eur Heart J Cardiovasc Imaging 20:932\u2013938. https:\/\/doi.org\/10.1093\/ehjci\/jey220","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2894_CR90","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1161\/CIRCULATIONAHA.121.054015","volume":"144","author":"B Raman","year":"2021","unstructured":"Raman B, Tunnicliffe EM, Chan K et al (2021) Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach. Circulation 144:1656\u20131658. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054015","journal-title":"Circulation"},{"key":"2894_CR91","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/cvr\/cvy147","volume":"114","author":"J van der Velden","year":"2018","unstructured":"van der Velden J, Tocchetti CG, Varricchi G et al (2018) Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology. Cardiovasc Res 114:1273\u20131280. https:\/\/doi.org\/10.1093\/cvr\/cvy147","journal-title":"Cardiovasc Res"},{"key":"2894_CR92","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","volume":"122","author":"K Abozguia","year":"2010","unstructured":"Abozguia K, Elliott P, McKenna W et al (2010) Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy. Circulation 122:1562\u20131569. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.934059","journal-title":"Circulation"},{"key":"2894_CR93","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00259-009-1350-3","volume":"37","author":"SAJ Timmer","year":"2010","unstructured":"Timmer SAJ, Germans T, G\u00f6tte MJW et al (2010) Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy. Eur J Nucl Med Mol Imaging 37:779\u2013788. https:\/\/doi.org\/10.1007\/s00259-009-1350-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2894_CR94","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0002-8703(97)70143-1","volume":"133","author":"S Ishiwata","year":"1997","unstructured":"Ishiwata S, Maruno H, Senda M et al (1997) Mechanical efficiency in hypertrophic cardiomyopathy assessed by positron emission tomography with carbon 11 acetate. Am Heart J 133:497\u2013503. https:\/\/doi.org\/10.1016\/s0002-8703(97)70143-1","journal-title":"Am Heart J"},{"key":"2894_CR95","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00109-008-0436-x","volume":"87","author":"M Luedde","year":"2009","unstructured":"Luedde M, Fl\u00f6gel U, Knorr M et al (2009) Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy. J Mol Med 87:411\u2013422. https:\/\/doi.org\/10.1007\/s00109-008-0436-x","journal-title":"J Mol Med"},{"key":"2894_CR96","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1532-429X-16-29","volume":"16","author":"M Mahmod","year":"2014","unstructured":"Mahmod M, Francis JM, Pal N et al (2014) Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction. J Cardiovasc Magn Reson 16:29. https:\/\/doi.org\/10.1186\/1532-429X-16-29","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR97","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","volume":"115","author":"SE Petersen","year":"2007","unstructured":"Petersen SE, Jerosch-Herold M, Hudsmith LE et al (2007) Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy. Circulation 115:2418\u20132425. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.657023","journal-title":"Circulation"},{"key":"2894_CR98","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/ehjci\/jeu137","volume":"15","author":"T Gyllenhammar","year":"2014","unstructured":"Gyllenhammar T, Fernlund E, Jablonowski R et al (2014) Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR. Eur Heart J Cardiovasc Imaging 15:1350\u20131357. https:\/\/doi.org\/10.1093\/ehjci\/jeu137","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2894_CR99","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.crad.2013.01.003","volume":"68","author":"L Huang","year":"2013","unstructured":"Huang L, Han R, Ai T et al (2013) Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: First-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T. Clin Radiol 68:676\u2013682. https:\/\/doi.org\/10.1016\/j.crad.2013.01.003","journal-title":"Clin Radiol"},{"key":"2894_CR100","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s10554-017-1189-9","volume":"33","author":"L Yin","year":"2017","unstructured":"Yin L, Xu H, Zheng S et al (2017) 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy. Int J Card Imaging 33:1949\u20131959. https:\/\/doi.org\/10.1007\/s10554-017-1189-9","journal-title":"Int J Card Imaging"},{"key":"2894_CR101","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.repc.2022.03.003","volume":"41","author":"P Garcia Br\u00e1s","year":"2022","unstructured":"Garcia Br\u00e1s P, Aguiar Rosa S, Thomas B et al (2022) Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonance segmental analysis. Rev Port Cardiol 41:559\u2013568. https:\/\/doi.org\/10.1016\/j.repc.2022.03.003","journal-title":"Rev Port Cardiol"},{"key":"2894_CR102","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cardfail.2011.01.006","volume":"17","author":"GD Aquaro","year":"2011","unstructured":"Aquaro GD, Todiere G, Barison A et al (2011) Myocardial Blood Flow and Fibrosis in Hypertrophic Cardiomyopathy. J Card Fail 17:384\u2013391. https:\/\/doi.org\/10.1016\/j.cardfail.2011.01.006","journal-title":"J Card Fail"},{"key":"2894_CR103","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0002-9149(90)91385-J","volume":"65","author":"BP Kimball","year":"1990","unstructured":"Kimball BP, LiPreti V, Bui S, Wigle ED (1990) Comparison of proximal left anterior descending and circumflex coronary artery dimensions in aortic valve stenosis and hypertrophic cardiomyopathy. Am J Cardiol 65:767\u2013771. https:\/\/doi.org\/10.1016\/0002-9149(90)91385-J","journal-title":"Am J Cardiol"},{"key":"2894_CR104","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0735-1097(96)00194-5","volume":"28","author":"P Kaufmann","year":"1996","unstructured":"Kaufmann P, Vassalli G, Lupi-Wagner S et al (1996) Coronary artery dimensions in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol 28:745\u2013750. https:\/\/doi.org\/10.1016\/0735-1097(96)00194-5","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR105","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jcct.2018.08.002","volume":"12","author":"SL Sellers","year":"2018","unstructured":"Sellers SL, Fonte TA, Grover R et al (2018) Hypertrophic Cardiomyopathy (HCM): New insights into Coronary artery remodelling and ischemia from FFRCT. J Cardiovasc Comput Tomogr 12:467\u2013471. https:\/\/doi.org\/10.1016\/j.jcct.2018.08.002","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2894_CR106","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ehjci\/jeab210","volume":"23","author":"A Das","year":"2022","unstructured":"Das A, Kelly C, Teh I et al (2022) Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes. Eur Heart J Cardiovasc Imaging 23:352\u2013362. https:\/\/doi.org\/10.1093\/ehjci\/jeab210","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2894_CR107","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/ehf2.13218","volume":"8","author":"M Hamada","year":"2021","unstructured":"Hamada M, Shigematsu Y, Nakata S et al (2021) Predicting the clinical course in hypertrophic cardiomyopathy using thallium-201 myocardial scintigraphy. ESC Heart Fail 8:1378\u20131387. https:\/\/doi.org\/10.1002\/ehf2.13218","journal-title":"ESC Heart Fail"},{"key":"2894_CR108","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0002-8703(98)70152-8","volume":"136","author":"R Lorenzoni","year":"1998","unstructured":"Lorenzoni R, Gistri R, Cecchi F et al (1998) Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. Am Heart J 136:972\u2013981. https:\/\/doi.org\/10.1016\/S0002-8703(98)70152-8","journal-title":"Am Heart J"},{"key":"2894_CR109","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.amjcard.2018.01.022","volume":"121","author":"D-Y Lu","year":"2018","unstructured":"Lu D-Y, Yal\u00e7in H, Yal\u00e7in F et al (2018) Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol 121:1081\u20131089. https:\/\/doi.org\/10.1016\/j.amjcard.2018.01.022","journal-title":"Am J Cardiol"},{"key":"2894_CR110","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000493005","volume":"141","author":"H Tian","year":"2018","unstructured":"Tian H, Yang C, Song Y et al (2018) Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy. Cardiology 141:202\u2013211. https:\/\/doi.org\/10.1159\/000493005","journal-title":"Cardiology"},{"key":"2894_CR111","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","author":"G Galati","year":"2016","unstructured":"Galati G, Leone O, Pasquale F et al (2016) Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003090","journal-title":"Circ Heart Fail"},{"key":"2894_CR112","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","volume":"40","author":"L Choudhury","year":"2002","unstructured":"Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156\u20132164. https:\/\/doi.org\/10.1016\/S0735-1097(02)02602-5","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR113","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1590\/s0066-782x2010005000017","volume":"94","author":"AA Shiozaki","year":"2010","unstructured":"Shiozaki AA, Senra T, Arteaga E et al (2010) Myocardial fibrosis in patients with hypertrophic cardiomyopathy and high risk for sudden death. Arq Bras Cardiol 94:535\u2013540. https:\/\/doi.org\/10.1590\/s0066-782x2010005000017","journal-title":"Arq Bras Cardiol"},{"key":"2894_CR114","doi-asserted-by":"publisher","first-page":"208","DOI":"10.7775\/RAC.84.3.7168","volume":"84","author":"A Deviggiano","year":"2016","unstructured":"Deviggiano A, Carrascosa P, Zan MD et al (2016) Wall Thickness and Patterns of Fibrosis in Hypertrophic Cardiomyopathy Assessed by Cardiac Magnetic Resonance Imaging. Rev Argent Cardiol 84:208\u2013214. https:\/\/doi.org\/10.7775\/RAC.84.3.7168","journal-title":"Rev Argent Cardiol"},{"key":"2894_CR115","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","volume":"56","author":"O Bruder","year":"2010","unstructured":"Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol 56:875\u2013887. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.007","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR116","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2967\/jnumed.107.050138","volume":"49","author":"B Sotgia","year":"2008","unstructured":"Sotgia B, Sciagr\u00e0 R, Olivotto I et al (2008) Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy. J Nucl Med 49:1090. https:\/\/doi.org\/10.2967\/jnumed.107.050138","journal-title":"J Nucl Med"},{"key":"2894_CR117","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00380-017-1088-y","volume":"33","author":"D Tezuka","year":"2018","unstructured":"Tezuka D, Kosuge H, Terashima M et al (2018) Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy. Heart Vessels 33:513\u2013520. https:\/\/doi.org\/10.1007\/s00380-017-1088-y","journal-title":"Heart Vessels"},{"key":"2894_CR118","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/hrt.2008.142562","volume":"95","author":"A Esposito","year":"2009","unstructured":"Esposito A, de Cobelli F, Perseghin G et al (2009) Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart 95:228. https:\/\/doi.org\/10.1136\/hrt.2008.142562","journal-title":"Heart"},{"key":"2894_CR119","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1172\/JCI42028","volume":"120","author":"P Teekakirikul","year":"2010","unstructured":"Teekakirikul P, Eminaga S, Toka O et al (2010) Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2. J Clin Invest 120:3520\u20133529. https:\/\/doi.org\/10.1172\/JCI42028","journal-title":"J Clin Invest"},{"key":"2894_CR120","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1007\/s00330-020-06779-9","volume":"30","author":"K Ando","year":"2020","unstructured":"Ando K, Nagao M, Watanabe E et al (2020) Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI. Eur Radiol 30:4327\u20134336. https:\/\/doi.org\/10.1007\/s00330-020-06779-9","journal-title":"Eur Radiol"},{"key":"2894_CR121","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s10554-011-9994-z","volume":"28","author":"S Kaimoto","year":"2012","unstructured":"Kaimoto S, Kawasaki T, Kuribayashi T et al (2012) Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy. Int J Card Imaging 28:1829\u20131839. https:\/\/doi.org\/10.1007\/s10554-011-9994-z","journal-title":"Int J Card Imaging"},{"key":"2894_CR122","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0735-1097(91)90869-B","volume":"17","author":"P Camici","year":"1991","unstructured":"Camici P, Chiriatti G, Lorenzoni R et al (1991) Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 17:879\u2013886. https:\/\/doi.org\/10.1016\/0735-1097(91)90869-B","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR123","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jjcc.2008.04.004","volume":"52","author":"W-S Kim","year":"2008","unstructured":"Kim W-S, Minagoe S, Mizukami N et al (2008) No reflow-like pattern in intramyocardial coronary artery suggests myocardial ischemia in patients with hypertrophic cardiomyopathy. J Cardiol 52:7\u201316. https:\/\/doi.org\/10.1016\/j.jjcc.2008.04.004","journal-title":"J Cardiol"},{"key":"2894_CR124","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1161\/01.CIR.96.12.4268","volume":"96","author":"E Lazzeroni","year":"1997","unstructured":"Lazzeroni E, Picano E, Morozzi L et al (1997) Dipyridamole-Induced Ischemia as a Prognostic Marker of Future Adverse Cardiac Events in Adult Patients With Hypertrophic Cardiomyopathy. Circulation 96:4268\u20134272. https:\/\/doi.org\/10.1161\/01.CIR.96.12.4268","journal-title":"Circulation"},{"key":"2894_CR125","doi-asserted-by":"publisher","first-page":"P144","DOI":"10.1186\/1532-429X-15-S1-P144","volume":"15","author":"F Gommans","year":"2013","unstructured":"Gommans F, Bakker J, Cramer E et al (2013) Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 15:P144. https:\/\/doi.org\/10.1186\/1532-429X-15-S1-P144","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR126","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0168-9525(03)00081-7","volume":"19","author":"H Ashrafian","year":"2003","unstructured":"Ashrafian H, Redwood C, Blair E, Watkins H (2003) Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet 19:263\u2013268. https:\/\/doi.org\/10.1016\/S0168-9525(03)00081-7","journal-title":"Trends Genet"},{"key":"2894_CR127","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1161\/01.CIR.97.25.2536","volume":"97","author":"W-I Jung","year":"1998","unstructured":"Jung W-I, Sieverding L, Breuer J et al (1998) 31P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy. Circulation 97:2536\u20132542. https:\/\/doi.org\/10.1161\/01.CIR.97.25.2536","journal-title":"Circulation"},{"key":"2894_CR128","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/1873-3468.13496","volume":"593","author":"V Sequeira","year":"2019","unstructured":"Sequeira V, Bertero E, Maack C (2019) Energetic drain driving hypertrophic cardiomyopathy. FEBS Lett 593:1616\u20131626. https:\/\/doi.org\/10.1002\/1873-3468.13496","journal-title":"FEBS Lett"},{"key":"2894_CR129","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrcardio.2009.9","volume":"6","author":"I Olivotto","year":"2009","unstructured":"Olivotto I, Cecchi F, Poggesi C, Yacoub MH (2009) Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis. Nat Rev Cardiol 6:317\u2013321. https:\/\/doi.org\/10.1038\/nrcardio.2009.9","journal-title":"Nat Rev Cardiol"},{"key":"2894_CR130","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3389\/fphys.2018.01391","volume":"9","author":"R Coppini","year":"2018","unstructured":"Coppini R, Ferrantini C, Mugelli A et al (2018) Altered Ca(2+) and Na(+) Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis. Front Physiol 9:1391. https:\/\/doi.org\/10.3389\/fphys.2018.01391","journal-title":"Front Physiol"},{"key":"2894_CR131","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.echo.2004.08.043","volume":"18","author":"H-J Youn","year":"2005","unstructured":"Youn H-J, Lee J-M, Park C-S et al (2005) The impaired flow reserve capacity of penetrating intramyocardial coronary arteries in apical hypertrophic cardiomyopathy. J Am Soc Echocardiogr 18:128\u2013132. https:\/\/doi.org\/10.1016\/j.echo.2004.08.043","journal-title":"J Am Soc Echocardiogr"},{"key":"2894_CR132","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0300-8932(00)75093-7","volume":"53","author":"A Guti\u00e9rrez D\u00edez","year":"2000","unstructured":"Guti\u00e9rrez D\u00edez A, Tamariz-Martel Moreno A, Ba\u00f1o Rodrigo A, Serrano Gonz\u00e1lez A (2000) Muerte s\u00fabita y fibrilaci\u00f3n ventricular de posible origen isqu\u00e9mico en un ni\u00f1o con miocardiopat\u00eda hipertr\u00f3fica. Rev Esp Cardiol 53:290\u2013293","journal-title":"Rev Esp Cardiol"},{"key":"2894_CR133","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.4103\/0366-6999.157656","volume":"128","author":"X-L Zhou","year":"2015","unstructured":"Zhou X-L, Xiao Y, Yang K-Q et al (2015) Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy. Chin Med J (Engl) 128:1483. https:\/\/doi.org\/10.4103\/0366-6999.157656","journal-title":"Chin Med J (Engl)"},{"key":"2894_CR134","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","volume":"47","author":"I Olivotto","year":"2006","unstructured":"Olivotto I, Cecchi F, Gistri R et al (2006) Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 47:1043\u20131048. https:\/\/doi.org\/10.1016\/j.jacc.2005.10.050","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR135","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/jcm10081547","volume":"10","author":"B Musumeci","year":"2021","unstructured":"Musumeci B, Tini G, Russo D et al (2021) Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge. J Clin Med 10:1547. https:\/\/doi.org\/10.3390\/jcm10081547","journal-title":"J Clin Med"},{"key":"2894_CR136","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s00259-016-3465-7","volume":"43","author":"H Castagnoli","year":"2016","unstructured":"Castagnoli H, Ferrantini C, Coppini R et al (2016) Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal. Eur J Nucl Med Mol Imaging 43:2413\u20132422. https:\/\/doi.org\/10.1007\/s00259-016-3465-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2894_CR137","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12968-019-0561-4","volume":"21","author":"P Freitas","year":"2019","unstructured":"Freitas P, Ferreira AM, Arteaga-Fern\u00e1ndez E et al (2019) The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death. J Cardiovasc Magn Reson 21:50. https:\/\/doi.org\/10.1186\/s12968-019-0561-4","journal-title":"J Cardiovasc Magn Reson"},{"key":"2894_CR138","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM199810223391704","volume":"339","author":"AT Yetman","year":"1998","unstructured":"Yetman AT, McCrindle BW, MacDonald C et al (1998) Myocardial Bridging in Children with Hypertrophic Cardiomyopathy \u2014 A Risk Factor for Sudden Death. N Engl J Med 339:1201\u20131209. https:\/\/doi.org\/10.1056\/NEJM199810223391704","journal-title":"N Engl J Med"},{"key":"2894_CR139","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/S0735-1097(00)00987-6","volume":"36","author":"SA Mohiddin","year":"2000","unstructured":"Mohiddin SA, Begley D, Shih J, Fananapazir L (2000) Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease. J Am Coll Cardiol 36:2270\u20132278. https:\/\/doi.org\/10.1016\/S0735-1097(00)00987-6","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR140","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0735-1097(03)00854-4","volume":"42","author":"P Sorajja","year":"2003","unstructured":"Sorajja P, Ommen SR, Nishimura RA et al (2003) Myocardial bridging in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 42:889\u2013894. https:\/\/doi.org\/10.1016\/S0735-1097(03)00854-4","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR141","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/bf03165056","volume":"10","author":"T Nishimura","year":"1996","unstructured":"Nishimura T, Nagata S, Uehara T et al (1996) Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography. Ann Nucl Med 10:71\u201378. https:\/\/doi.org\/10.1007\/bf03165056","journal-title":"Ann Nucl Med"},{"key":"2894_CR142","doi-asserted-by":"publisher","first-page":"E1308","DOI":"10.1016\/S0735-1097(13)61308-X","volume":"61","author":"A Makoto","year":"2013","unstructured":"Makoto A, Toshiharu T, Naka S et al (2013) Microcirculatory dysfunction determines the long-term prognosis in asymptomatic patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 61:E1308\u2013E1308. https:\/\/doi.org\/10.1016\/S0735-1097(13)61308-X","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR143","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5339\/gcsp.2015.51","volume":"2015","author":"G Quarta","year":"2015","unstructured":"Quarta G, Iacovoni A, Marrone C et al (2015) Microvascular ischaemia after cardiac arrest in a patient with hypertrophic cardiomyopathy. Glob Cardiol Sci Pract 2015:51. https:\/\/doi.org\/10.5339\/gcsp.2015.51","journal-title":"Glob Cardiol Sci Pract"},{"key":"2894_CR144","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.hrcr.2018.03.004","volume":"4","author":"E Rochelson","year":"2018","unstructured":"Rochelson E, Nappo L, Pass RH (2018) Hypertrophic cardiomyopathy: Ischemia progressing to ventricular fibrillation. Hear Case Rep 4:386\u2013388. https:\/\/doi.org\/10.1016\/j.hrcr.2018.03.004","journal-title":"Hear Case Rep"},{"key":"2894_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2019.100452","author":"P Magnusson","year":"2020","unstructured":"Magnusson P, Nordstr\u00f6m J, Harms HJ et al (2020) Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. IJC Heart Vasc. https:\/\/doi.org\/10.1016\/j.ijcha.2019.100452","journal-title":"IJC Heart Vasc"},{"key":"2894_CR146","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1093\/oxfordjournals.eurheartj.a015204","volume":"18","author":"R Lorenzoni","year":"1997","unstructured":"Lorenzoni R, Gistri R, Cecchi F et al (1997) Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function. Eur Heart J 18:1946\u20131950. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a015204","journal-title":"Eur Heart J"},{"key":"2894_CR147","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12350-008-9005-5","volume":"16","author":"R Sciagr\u00e0","year":"2009","unstructured":"Sciagr\u00e0 R, Sotgia B, Olivotto I et al (2009) Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol 16:92\u201396. https:\/\/doi.org\/10.1007\/s12350-008-9005-5","journal-title":"J Nucl Cardiol"},{"key":"2894_CR148","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1536\/ihj.20-479","volume":"62","author":"J Komuro","year":"2021","unstructured":"Komuro J, Iguchi N, Utanohara Y et al (2021) Prediction of Serious Adverse Events of Patients with Hypertrophic Cardiomyopathy by Magnetic Resonance. Int Heart J 62:135\u2013141. https:\/\/doi.org\/10.1536\/ihj.20-479","journal-title":"Int Heart J"},{"key":"2894_CR149","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","volume":"27","author":"PM Elliott","year":"2006","unstructured":"Elliott PM, Gimeno JR, Tom\u00e9 MT et al (2006) Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27:1933\u20131941. https:\/\/doi.org\/10.1093\/eurheartj\/ehl041","journal-title":"Eur Heart J"},{"issue":"ehaa946","key":"2894_CR150","doi-asserted-by":"publisher","first-page":"0732","DOI":"10.1093\/ehjci\/ehaa946.0732","volume":"41","author":"G Norrish","year":"2020","unstructured":"Norrish G, Ding T, Field E et al (2020) The relationship between left ventricular outflow tract gradient and sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur Heart J 41(ehaa946):0732. https:\/\/doi.org\/10.1093\/ehjci\/ehaa946.0732","journal-title":"Eur Heart J"},{"key":"2894_CR151","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.119.040271","volume":"140","author":"A Weissler-Snir","year":"2019","unstructured":"Weissler-Snir A, Allan K, Cunningham K et al (2019) Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario. Circulation 140:1706\u20131716. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040271","journal-title":"Circulation"},{"key":"2894_CR152","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijcard.2021.06.051","volume":"339","author":"T Rodrigues","year":"2021","unstructured":"Rodrigues T, Raposo SC, Brito D, Lopes LR (2021) Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review Int J Cardiol 339:83\u201392. https:\/\/doi.org\/10.1016\/j.ijcard.2021.06.051","journal-title":"A systematic review Int J Cardiol"},{"key":"2894_CR153","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.amjmed.2015.12.027","volume":"129","author":"AJ Ullal","year":"2016","unstructured":"Ullal AJ, Abdelfattah RS, Ashley EA, Froelicher VF (2016) Hypertrophic Cardiomyopathy as a Cause of Sudden Cardiac Death in the Young: A Meta-Analysis. Am J Med 129:486-496.e2. https:\/\/doi.org\/10.1016\/j.amjmed.2015.12.027","journal-title":"Am J Med"},{"key":"2894_CR154","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tcm.2021.06.001","volume":"32","author":"F D\u2019Ascenzi","year":"2021","unstructured":"D\u2019Ascenzi F, Valentini F, Pistoresi S et al (2021) Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young. Trends Cardiovasc Med 32:299\u2013308. https:\/\/doi.org\/10.1016\/j.tcm.2021.06.001","journal-title":"Trends Cardiovasc Med"},{"key":"2894_CR155","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bjsports-2020-102921","volume":"55","author":"JA Drezner","year":"2021","unstructured":"Drezner JA, Malhotra A, Prutkin JM et al (2021) Return to play with hypertrophic cardiomyopathy: are we moving too fast? A critical review. Br J Sports Med 55:1041. https:\/\/doi.org\/10.1136\/bjsports-2020-102921","journal-title":"Br J Sports Med"},{"key":"2894_CR156","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","volume":"30","author":"JR Gimeno","year":"2009","unstructured":"Gimeno JR, Tom\u00e9-Esteban M, Lofiego C et al (2009) Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur Heart J 30:2599\u20132605. https:\/\/doi.org\/10.1093\/eurheartj\/ehp327","journal-title":"Eur Heart J"},{"key":"2894_CR157","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/heartjnl-2015-308453","volume":"102","author":"D Magr\u00ec","year":"2016","unstructured":"Magr\u00ec D, Limongelli G, Re F et al (2016) Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy. Heart 102:602. https:\/\/doi.org\/10.1136\/heartjnl-2015-308453","journal-title":"Heart"},{"key":"2894_CR158","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.002248","volume":"8","author":"CJ Coats","year":"2015","unstructured":"Coats CJ, Rantell K, Bartnik A et al (2015) Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy. Circ Heart Fail 8:1022\u20131031. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.002248","journal-title":"Circ Heart Fail"},{"key":"2894_CR159","doi-asserted-by":"publisher","first-page":"H129","DOI":"10.1152\/ajpheart.00077.2011","volume":"301","author":"SAJ Timmer","year":"2011","unstructured":"Timmer SAJ, Knaapen P, Germans T et al (2011) Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy. Am J Physiol Heart Circ Physiol 301:H129\u2013H137. https:\/\/doi.org\/10.1152\/ajpheart.00077.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2894_CR160","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jtcvs.2003.11.003","volume":"128","author":"M J\u00f6rg-Ciopor","year":"2004","unstructured":"J\u00f6rg-Ciopor M, Namdar M, Turina J et al (2004) Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy. J Thorac Cardiovasc Surg 128:163\u2013169. https:\/\/doi.org\/10.1016\/j.jtcvs.2003.11.003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2894_CR161","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2353\/jmoldx.2009.080082","volume":"11","author":"M Penicka","year":"2009","unstructured":"Penicka M, Gregor P, Kerekes R et al (2009) The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study. J Mol Diagn 11:35\u201341. https:\/\/doi.org\/10.2353\/jmoldx.2009.080082","journal-title":"J Mol Diagn"},{"issue":"ehaa946","key":"2894_CR162","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1093\/ehjci\/ehaa946.3360","volume":"41","author":"H Maqsood","year":"2020","unstructured":"Maqsood H, Shakeel HA, Shoukat HF et al (2020) Effects of candesartan on left ventricular hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. Eur Heart J 41(ehaa946):3360. https:\/\/doi.org\/10.1093\/ehjci\/ehaa946.3360","journal-title":"Eur Heart J"},{"key":"2894_CR163","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41591-021-01505-4","volume":"27","author":"CY Ho","year":"2021","unstructured":"Ho CY, Day SM, Axelsson A et al (2021) Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. Nat Med 27:1818\u20131824. https:\/\/doi.org\/10.1038\/s41591-021-01505-4","journal-title":"Nat Med"},{"key":"2894_CR164","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ahj.2021.06.010","volume":"240","author":"R Ananthakrishna","year":"2021","unstructured":"Ananthakrishna R, Lee SL, Foote J et al (2021) Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial). Am Heart J 240:101\u2013113. https:\/\/doi.org\/10.1016\/j.ahj.2021.06.010","journal-title":"Am Heart J"},{"key":"2894_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020411","author":"A Cogolludo","year":"2019","unstructured":"Cogolludo A, Villamor E, Perez-Vizcaino F, Moreno L (2019) Ceramide and Regulation of Vascular Tone. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20020411","journal-title":"Int J Mol Sci"},{"key":"2894_CR166","doi-asserted-by":"publisher","first-page":"23","DOI":"10.12997\/jla.2020.9.1.23","volume":"9","author":"A Kovilakath","year":"2020","unstructured":"Kovilakath A, Cowart LA (2020) Sphingolipid Mediators of Myocardial Pathology. J Lipid Atheroscler 9:23\u201349","journal-title":"J Lipid Atheroscler"},{"key":"2894_CR167","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jacbts.2019.06.004","volume":"4","author":"R Coppini","year":"2019","unstructured":"Coppini R, Ferrantini C, Pioner Jos\u00e8 M et al (2019) Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol Basic Trans Science 4:795\u2013813. https:\/\/doi.org\/10.1016\/j.jacbts.2019.06.004","journal-title":"J Am Coll Cardiol Basic Trans Science"},{"key":"2894_CR168","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004124","author":"I Olivotto","year":"2018","unstructured":"Olivotto I, Camici PG, Merlini PA et al (2018) Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004124","journal-title":"Circ Heart Fail"},{"key":"2894_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.10.014","author":"A Argir\u00f2","year":"2022","unstructured":"Argir\u00f2 A, Zampieri M, Dei L-L et al (2022) Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: real-world experience in a National Referral Center. Int J Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2022.10.014","journal-title":"Int J Cardiol"},{"key":"2894_CR170","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002764","author":"I Olivotto","year":"2016","unstructured":"Olivotto I, Hellawell JL, Farzaneh-Far R et al (2016) Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002764","journal-title":"Circ Heart Fail"},{"key":"2894_CR171","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","volume":"45","author":"MV Sherrid","year":"2005","unstructured":"Sherrid MV, Barac I, McKenna WJ et al (2005) Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 45:1251\u20131258. https:\/\/doi.org\/10.1016\/j.jacc.2005.01.012","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR172","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s40265-022-01728-w","volume":"82","author":"C Palandri","year":"2022","unstructured":"Palandri C, Santini L, Argir\u00f2 A et al (2022) Pharmacological Management of Hypertrophic Cardiomyopathy: from Bench to Bedside. Drugs 82:889\u2013912. https:\/\/doi.org\/10.1007\/s40265-022-01728-w","journal-title":"Drugs"},{"key":"2894_CR173","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto I, Oreziak A, Barriales-Villa R et al (2020) Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 396:759\u2013769. https:\/\/doi.org\/10.1016\/S0140-6736(20)31792-X","journal-title":"Lancet"},{"key":"2894_CR174","doi-asserted-by":"publisher","first-page":"949","DOI":"10.33963\/KP.a2021.0064","volume":"79","author":"P Pysz","year":"2021","unstructured":"Pysz P, Rajtar-Salwa R, Smolka G et al (2021) Mavacamten - a new disease-specific option for pharmacological treatment of symptomatic patients with hypertrophic cardiomyopathy. Kardiol Pol 79:949\u2013954","journal-title":"Kardiol Pol"},{"key":"2894_CR175","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","volume":"75","author":"CY Ho","year":"2020","unstructured":"Ho CY, Mealiffe ME, Bach RG et al (2020) Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol 75:2649\u20132660. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.064","journal-title":"J Am Coll Cardiol"},{"key":"2894_CR176","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1161\/CIRCULATIONAHA.122.062699","volume":"147","author":"J Conway","year":"2022","unstructured":"Conway J, Min S, Villa C et al (2022) The Prevalence and Association of Exercise Test Abnormalities with Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Circulation 147:718\u2013727. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062699","journal-title":"Circulation"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02894-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-023-02894-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02894-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T06:18:22Z","timestamp":1697782702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-023-02894-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":176,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1007\/s10554-023-02894-y","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"14 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}